Using gene expression data to direct breast cancer therapy: evidence from a preclinical trial

Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte
Shams ReazEran R Andrechek

Abstract

The heterogeneity both within and between breast cancers presents a significant clinical challenge for both diagnosis and therapy. This heterogeneity is present at all levels of analysis in breast cancer, ranging from genomic to metabolomic. A function of this heterogeneity is that numerous signaling networks are activated, and while treatment of one arm may be initially effective, this allows the tumor to be poised to evolve a resistance mechanism. Here we review the classification of breast cancers and discuss therapy of hormone positive, HER2 positive, and triple negative breast cancers. Model systems for breast cancer are examined allowing for a preclinical trial using a personalized medicine approach to be tested. This preclinical trial was based solely on cell signaling pathway activation and effectively and specifically blocked tumor growth in a preclinical model system.

References

Aug 4, 1999·Proceedings of the National Academy of Sciences of the United States of America·C M PerouD Botstein
Aug 30, 2000·Nature·C M PerouD Botstein
Sep 13, 2001·Proceedings of the National Academy of Sciences of the United States of America·T SørlieA L Børresen-Dale
Sep 20, 2001·Proceedings of the National Academy of Sciences of the United States of America·M WestJ R Nevins
Feb 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Charles L VogelMichael Press
Jun 28, 2003·Proceedings of the National Academy of Sciences of the United States of America·Therese SorlieDavid Botstein
Sep 10, 2005·Cancer Immunology, Immunotherapy : CII·Camellia W AdamsMark X Sliwkowski
Jul 26, 2007·BMC Cancer·Marc TischkowitzWilliam D Foulkes
Aug 3, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Rebecca DentSteven A Narod
Oct 13, 2007·Science·Laura D WoodBert Vogelstein
Jun 14, 2008·Development·Eran R AndrechekJoseph R Nevins
Oct 7, 2009·Proceedings of the National Academy of Sciences of the United States of America·Eran R AndrechekJoseph R Nevins
Mar 26, 2010·Proceedings of the National Academy of Sciences of the United States of America·Michael L GatzaJoseph R Nevins
Aug 18, 2010·Proceedings of the National Academy of Sciences of the United States of America·Joseph H TaubeSendurai A Mani
Sep 4, 2010·Breast Cancer Research : BCR·Aleix PratCharles M Perou
Jan 15, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ana M Gonzalez-AnguloFunda Meric-Bernstam
Jan 20, 2011·Cancer Research·Kenichiro FujiwaraEran R Andrechek
Jun 3, 2011·Proceedings of the National Academy of Sciences of the United States of America·Jason I HerschkowitzJeffrey M Rosen
Oct 14, 2011·The New England Journal of Medicine·Dennis SlamonUNKNOWN Breast Cancer International Research Group
Dec 14, 2011·The New England Journal of Medicine·José BaselgaGabriel N Hortobagyi
Apr 18, 2012·Nature Reviews. Clinical Oncology·John J TentlerS Gail Eckhardt
Sep 25, 2012·Nature·UNKNOWN Cancer Genome Atlas Network
Nov 5, 2013·Nature Genetics·Dan R RobinsonArul M Chinnaiyan
Jul 23, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Felipe AdesMartine Piccart
Jul 30, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sylvia AdamsSunil S Badve
Sep 12, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Matthew D BursteinPowel H Brown
Oct 10, 2015·Cell·Giovanni CirielloCharles M Perou

❮ Previous
Next ❯

Citations

Dec 2, 2020·Materials Science & Engineering. C, Materials for Biological Applications·Jiafeng ZhuangPing Wang
Feb 9, 2021·Journal of Cancer Research and Clinical Oncology·Brian A KellerJohn C Bell

❮ Previous
Next ❯

Methods Mentioned

BETA
xenograft
biopsy

Related Concepts

Related Feeds

Breast Tumorigenesis

Breast tumorigenesis involves the production or formation of tumor(s) in breast tissue. Discover the latest research on breast tumorigenesis here.

Cancer -Omics

A variety of different high-throughput technologies can be used to identify the complete catalog of changes that characterize the molecular profile of cohorts of tumor samples. Discover the latest insights gained from cancer 'omics' in this feed.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Antiparasitics

Antiparasitics are medications which are indicated for the treatment of parasitic diseases. Discover the latest research on antiparasitics here.

Related Papers

Nihon rinsho. Japanese journal of clinical medicine
Kiyohiko Hatake
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Michail IgnatiadisMartine Piccart
Clinical Chemistry and Laboratory Medicine : CCLM
Bohuslav Melichar, Mario Plebani
© 2022 Meta ULC. All rights reserved